Non-Cutaneous Immune-Related Adverse Events Predict Overall and Progression-Free Survival in Patients With Cutaneous Toxicities After ICI Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Non-cutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapy
J Am Acad Dermatol 2023 Jan 31;[EPub Ahead of Print], MS Asdourian, TV Jacoby, N Shah, T Otto, LL Thompson, EC Dee, KL Reynolds, YR Semenov, ST ChenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.